[1]
|
To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations
Journal of Biomolecular Structure and Dynamics,
2023
DOI:10.1080/07391102.2022.2107074
|
|
|
[2]
|
To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations
Journal of Biomolecular Structure and Dynamics,
2022
DOI:10.1080/07391102.2022.2107074
|
|
|
[3]
|
To Probe the Binding Interactions between Two FDA Approved Migraine Drugs (Ubrogepant and Rimegepant) and Calcitonin-Gene Related Peptide Receptor (CGRPR) Using Molecular Dynamics Simulations
ACS Chemical Neuroscience,
2021
DOI:10.1021/acschemneuro.1c00135
|
|
|
[4]
|
Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations
ACS Chemical Neuroscience,
2021
DOI:10.1021/acschemneuro.1c00126
|
|
|
[5]
|
To Probe the Binding Interactions between Two FDA Approved Migraine Drugs (Ubrogepant and Rimegepant) and Calcitonin-Gene Related Peptide Receptor (CGRPR) Using Molecular Dynamics Simulations
ACS Chemical Neuroscience,
2021
DOI:10.1021/acschemneuro.1c00135
|
|
|
[6]
|
Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations
ACS Chemical Neuroscience,
2021
DOI:10.1021/acschemneuro.1c00126
|
|
|
[7]
|
LISS2019
2020
DOI:10.1007/978-981-15-5682-1_11
|
|
|
[8]
|
Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT1b) Using Molecular Dynamics Simulations and Dynamic Network Analysis
Journal of Chemical Information and Modeling,
2020
DOI:10.1021/acs.jcim.9b01082
|
|
|
[9]
|
Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT1b) Using Molecular Dynamics Simulations and Dynamic Network Analysis
Journal of Chemical Information and Modeling,
2020
DOI:10.1021/acs.jcim.9b01082
|
|
|
[10]
|
Dopamine D4 Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy
Journal of Medicinal Chemistry,
2019
DOI:10.1021/acs.jmedchem.9b00231
|
|
|
[11]
|
Dopamine D4 Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy
Journal of Medicinal Chemistry,
2019
DOI:10.1021/acs.jmedchem.9b00231
|
|
|